© 2026 Recor Medical, Inc. All rights reserved.

The PARADISE™ system is FDA approved for sale in the United States and is CE marked (2797) and approved for sale in markets where the CE mark is accepted, in accordance with its approved indications for use, and has received regulatory approval in Japan.

RECOR MEDICAL, PARADISE, HYDROCOOLING, SONOWAVE 360, RADIANCE and the Swirl logo are registered trademarks in the European Union and certain other jurisdictions of Recor Medical, Inc. or Otsuka Medical Devices Co., Ltd., as applicable. The GPS logo, RECOR and the RADIANCE logo are trademarks of Recor Medical, Inc. Trademarks owned by Otsuka Medical Devices Co., Ltd. are used by Recor Medical, Inc. under license.

Important Safety Information
Prescription Only. Brief Summary – Prior to use, please reference the Instructions for Use

Indications for Use
The Paradise Catheter is indicated for percutaneous renal denervation.

Results may vary. The most common risks include pain, vascular site injury and vasospasm. See full important safety information: https://www.recormedical.eu/paradise-ultrasound-rdn-system/#safety

Recor Medical, headquartered in Palo Alto, California, USA, a wholly owned subsidiary of Otsuka Medical Devices Co., Ltd. recormedical.eu is Recor Medical Europe GmbH website (the Site). We control and operate this Site from Europe. This Site is intended for use by European residents only and contains information regarding the Paradise™ System, which is approved for sale in the EU and bears a CE mark.

Recor Medical Europe GmbH
Europa-Allee 52 · 60327 Frankfurt · Germany
Amtsgericht Frankfurt am Main: HRB 123214
Managing Directors: Michael Jones, Ronan O’Connor